Clinical Trial Update: A Study to Compare Quality of Life and Compliance in Patients Receiving High-dose Interferon Versus Pegylated Interferon in Patients With Surgically Resected Melanoma

View source ↗

Summary

A completed clinical trial comparing high-dose interferon with pegylated interferon in patients with surgically resected melanoma. The study reports on quality …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interferon alfa-2b (high-dose) (Interferon alfa-2b)
• Peginterferon alfa-2b (Peginterferon alfa-2b)

Snippet

Sponsor: St. Luke's Hospital and Health Network, Pennsylvania | Conditions: Melanoma | Status: COMPLETED | Results posted: 2025-02-13